Long-term Survival Data from Longeveron's ELPIS 1 Trial
Extended Follow Up Data Show Continued, Transplant Free Survival of All Patients Results Support Continued Investigation of Lomecel-BTM As Adjunct to...
Source: globenewswire.com
Glenn Procedure News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Glenn Procedure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Glenn Procedure Today - Breaking & Trending Today
5-month-old baby's successful heart surgery highlights importance of life-saving research
Surgeon and physician Dr. Aaron Abarbanel says Dante was diagnosed with a rare heart defect that posed severe health risks, making Dante’s chances of survival uncertain.
Source: ksat.com
Longeveron Inc. (NASDAQ:LGVN) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Longeveron's call today to discuss the company's 2023 First Quarter and Financial Results. All participants are currently in listen-only mode.
Source: insidermonkey.com
Longeveron Announces Publication of Final Data from ELPIS I Trial of Lomecel-BTM for Hypoplastic Left Heart Syndrome in Peer-Reviewed Journal
19.01.2023 - - Full results published in European Heart Journal Open - - Study met primary safety endpoint - - All patients alive, transplant-free, and maintained expected rate of growth one year after treatment - - Data supports ongoing clinical ... Seite 1
Source: wallstreet-online.de